Schedule 13G ownership disclosure

Acumen Pharmaceuticals, Inc.

Common stock, par value $0.0001 per share · CUSIP: 00509G209

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Franklin Resources, Inc.

    Shares: 2,305,096.00 · Class: 3.8%

  • Charles B. Johnson

    Shares: 0.00 · Class: 0%

  • Rupert H. Johnson, Jr.

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000038777-25-000217
Form type
SCHEDULE 13G/A
Filer
Acumen Pharmaceuticals, Inc.
CIK
CIK 1576885
Filed
Nov 04, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub